Editorial Board

57 Editors in 14 Countries/Regions

China (20)
United States (12)
Italy (8)
Germany (3)
Portugal (3)
Netherlands (2)
United Kingdom (2)
Belgium (1)
Greece (1)
India (1)
Israel (1)
Japan (1)
Russia (1)
Taiwan (1)

Honorary Editors-in-Chief

Dai-Ming Fan

[email protected]

State Key Laboratory of Cancer Biology and Xijing Hospital of Digestive Diseases, The Fourth Military Medical University, Xi'an, Shaanxi, China

Research Interests: identification and application of gastric cancer associated antigens, multi-drug resistance of gastric cancer, immunogenetics and pathogenesis of gastric cancer

Yan Sun

Academician of Chinese Society of Engineering, Beijing, China

Research Interests: clinical oncology, non-small cell lung cancer, breast cancer, target therapy

Advisory Editors

Michael Atkins

Division of Hematology/Oncology, MedStar Georgetown University Hospital, Washington, USA

Research Interests: Anti-angiogenic Therapy, Cytokines, Hematology, Immunotherapy, Kidney Cancer, Mechanisms of Resistance, Melanoma, Molecularly Targeted Therapy, Predictive Biomarkers, Translational Research

Contributions:

Current and Emerging therapies for first line treatment of metastatic clear cell renal cell carcinoma

Alfio Wo Ferlito

Coordinator of the International Head and Neck Scientific Group, Padua, Italy

Research Interests: head and neck surgery, laryngology

Yudong Zhang

School of Computing and Mathematical Sciences, University of Leicester, Leicester, United Kingdom

Research Interests: deep learning, cancer detection, prognosis, prediction, treatment

Senior Editor

Timothy M. Pawlik

Department of Surgery, The Ohio State University College of Medicine,Columbus, USA

Research Interests: small intestine cancer, liver cancers, pancreatic cancers, gallbladder cancers, gastrointestinal cancers, neuroendocrine tumors

Contributions:

Factors Associated with Prognosis and Staging of Intrahepatic Cholangiocarcinoma

Surgical Approach to Hepatocellular Carcinoma: A Review

Special Issue:

Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma

Recent Developments in the Surgical Management of Hepatocellular Carcinoma

Associate Editors

Sanjun Cai

Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.

Research Interests: colorectal cancer, gastric cancer, retroperitoneal soft tissue tumors, malignant melanoma

Gopal C. Kundu

KIIT Deemed to be University, Institute of Eminence, Bhubaneswar, India

Research Interests: tumor biology, cancer stem cells, tumor-stroma interaction, angiogenesis, cancer therapeutics biomarker development, nanomedicine

Christos Papadimitriou

Oncology Unit, Second Department of Surgery, “Aretaieion” University Hospital, National and Kapodistrian University of Athens, Athens, Greece

Research Interests: bone marrow transplantation, gynecologic cancer, breast cancer, lung cancer, GI cancers

Contributions:

The Role of Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer: Recent Developments and Future Perspectives

Neoadjuvant treatment of pancreatic ductal adenocarcinoma: present and future

Godefridus J. Peters

Laboratory Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands

Research Interests: pharmacology of anticancer agents, antimetabolites, antifolates, platinum analogs, taxanes, anti-signalling agents, third generation targeted-agents

Contributions:

Gemcitabine followed by radiotherapy in treatment of newly diagnosed high-grade gliomas

Special Issue:

Cancer Pharmacogenomics

Haisheng Qian

School of Biomedical Engineering, Anhui Medical University, Hefei, Anhui, China.

Research Interests: biomaterials, drug delivery and biomedical engineering

Jan Baptist Vermorken

Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium

Research Interests: gynecologic oncology, head and neck oncology, breast and colon cancer

Masayuki Watanabe

Department of Gastroenterological Surgery, Esophageal Cancer Division, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan

Research Interests: esophageal surgery, esophageal squamous cell carcinoma, noncurative endoscopic resection, upfront esophagectomy, minimally invasive surgery

Contributions:

Risk factors and molecular mechanisms of esophageal cancer: differences between the histologic subtypes

Introduction to Volume 1 Issue 3 of Journal of Cancer Metastasis and Treatment

Epigenetic changes in gastrointestinal cancers

Overview of genetic and epigenetic alterationsin the pathogenesis of esophagogastric junctional adenocarcinoma and esophageal adenocarcinoma: recent findings by next generation sequencing

The clinical significance of circulating tumor cells in gastrointestinal cancer

Chronic inflammation and gastrointestinal cancer

MicroRNAs in gastrointestinal cancer: a novel biomarker and its clinical application

Trends in clinical use of targeted therapy for gastrointestinal cancers

Conversion surgery for stage IV gastric cancer

Treatment strategy for metastatic gastric cancer in Japan

Management of metastatic esophagogastric junction adenocarcinoma

Recent updates of therapeutic strategy of esophagogastric junction adenocarcinoma

Serum Squamous Cell Carcinoma Antigen is a Predictive Factor of Outcomes in Patients with Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma Treated by Definitive Chemoradiotherapy

Special Issue:

Reviews of Recent Advances in Research and Treatment for Gastroenterological Malignancies

Reviews of Gastric Cancer Metastasis and Treatment

Management of Esophageal Cancer

Editorial Board Members

Consuelo Amantini

School of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy

Research Interests: transient receptor potential receptors, cancer cell line models, cellular pathways, autophagy, anti-cancer drug mechanisms

Contributions:

Cross-talk between microRNA, Long non-coding RNAs and P21/CIP1 in glioma: diagnostic, prognostic and therapeutic role.

Jin-Xin Bei

State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangdong, China

Research Interests: tumor heterogeneity, genetics and genomics, viral infection, tumor microenvironment, therapeutic resistance, precision medicine

William L. Blalock

CNR, Istituto Di Genetica Molecolare "Luigi Luca Cavalli Sforza", Bologna, Italy

Research Interests: leukemia, osteosarcoma, RNA editing/metabolism/splicing, inflammation/stress signaling

Stergios Boussios

Department of Medical Oncology, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK; School of Cancer & Pharmaceutical Sciences, King's College London, Strand, London WC2R 2LS, UK; Kent Medway Medical School, University of Kent, Canterbury CT2 7LX, UK; Faculty of Medicine, Health and Social Care, Canterbury Christ Church University, Canterbury CT2 7PB, UK.

Research Interests: Urological cancers, Gynaecological cancer, Colorectal cancer, Melanoma, Biomarkers, Homologous recombination of DNA, PARP inhibitors

Xiaofang Che

Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China

Research Interests: translational research on precise diagnosis and treatment of gastrointestinal tumors based on hypoxia and immune microenvironment, anti-tumor peptide development, tumor metastasis and drug resistance mechanism, tumor peptide development, tumor metastasis and drug resistance mechanism research

Contributions:

Neutrophils in the tumor microenvironment: role in tumor progression and potential targeted therapeutic strategy

Special Issue:

The Role of the Immune Micro-environment in Tumour Metastasis and Therapeutic Strategies

Immunotherapy in Gastrointestinal Tumors

Novel Therapeutic Targeting Approaches to Cancer Therapy Resistance Mechanism

Chun Hei Antonio Cheung

Director of Office of Overseas Students and Scholars Services &Director of Global Competence Advancement Center, Office of International Affairs (OIA);National Cheng Kung University (NCKU), Tainan, Taiwan

Research Interests: anti-cancer nanodrug development, cancer drug resistance mechanism, cancer cell autophagy

Contributions:

Introduction to this special issue - “Autophagy and Cancer: current biology and drug development”

Special Issue:

Autophagy and Cancer: Current Biology and Drug Development

Daxiang Cui

School of Sensing Science and Engineering, Shanghai Jiao Tong University, Shanghai, China

Research Interests: nano biomedicine and biosensor, cancer prewarning and early theranostics, intelligent detection instrument, molecular imaging and nanoprobes

Pedro Fonte

Centre of Marine Sciences (CCMAR), Campus de Gambelas, Universidade do Algarve, Faro, Portugal.

Research Interests: drug delivery, nanomedicine, oral delivery of therapeutic proteins, wound healing, lyophilization of biopharmaceuticals, cancer treatment

Arjan W. Griffioen

Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, Netherlands

Research Interests: genetic profiling of tumor endothelium, cancer vaccines, combination therapy, personalized therapy

Guohong Han

Department of Oncology, Xi'an International Medical Center Hospital, Xi'an, Shaanxi , China.

Research Interests: gastrointestinal neoplasms

Dae Joong Kim

Department of Microbiology, Immunology and Cancer Biology, University of Virginia, VA, USA

Research Interests: cancer biology, tumor angiogenesis, tumor immunology, actin dynamics, vascular biology

Yuanyuan Lu

State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, National Clinical Research Center for Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China

Research Interests: gastrointestinal cancer

Yuxia Luan

School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan,Shandong, China.

Research Interests: drug delivery systems and tumor therapy,drug carrier development and formulation, biomedical materials

Dario Marchetti

Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, USA

Research Interests: circulating tumor cells, liquid biopsy, biomarkers, cancer metastasis, transcriptomics

Special Issue:

Application of Liquid Biopsy for Prognostic Status of Cancers and Drug Response

Palanisamy Nallasamy

Department of Biochemistry and Molecular Biology, University of Nebraska Medical Centre, Omaha, USA

Research Interests: pancreatic cancer, stem cells, tumor microenvironment, small molecule therapeutics, cardiovascular disease, experimental diabetes

Special Issue:

Novel Therapeutic Targeting Approaches to Cancer Therapy Resistance Mechanism

Jingxuan Pan

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou , Guangdong, China.

Research Interests: cancer stem cells, liver metastasis, resistance, tumor molecular targeted therapy, pharmacological intervention

Pier Paolo Piccaluga

Biobank of Research, IRCCS Azienda Opedaliera-Universitaria di Bologna; Institute of Hematology and Medical Oncology “L&A Seràgnoli” - Department of Medical and Surgical Sciences, University of Bologna, Italy

Research Interests: hematology, hematopathology, targeted therapy, molecular diagnostics, leukemia, lymphoma, drug resistance, cancer metabolism, genomics

Special Issue:

Applications and Future Prospects of AI in Cancer

Advanced Technologies in Service Robots: Design, Control, and AI Approaches for Enhanced Human Assistance

Advances in Genomic and Metabolic Landscapes of Acute Myeloid Leukemia

Giuliano Ramadori

Professor of Medicine, Gastroenterology and Endocrinology, University Medical Center Göttingen, Göttingen, Germany

Research Interests: gene expression, liver cells (hepatocytes, kupffer cells, endothelial cells, stellate cells), pathogenesis, inflammation, cancer development, animal models of liver cancer diagnostic procedures and therapy, COVID-19 diagnostic and treatment, mechanisms of acute-phaseresponse, gastrointestinal cancer diagnostic and endoscopic therapy, systemic cancer therapy, tumor microenviroment analysis, liver diseases diagnostic, therapy, iron metabolism, radiation biology

Boris Reva

Department of Genetics and Genomic Sciences, Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Research Interests: molecular diagnostics, clinical subtypes and precise medicine of cancer, cancer genomics and immune therapy

Lúcio Lara Santos

Department of Surgical Oncology, Portuguese Oncology Institute-Porto (IPO-Porto), Porto, Portugal

Research Interests: surgical oncology and carcinogenesis, experimental pathology and oncology, gastrointestinal, breast cancer, cancers related to infections

Marcus Schmidt

Department of Obstetrics and Gynecology, Comprehensive Cancer Center, University Medical Center Mainz, Langenbeckstr, Mainz, Germany

Research Interests: prognostic and predictive factors in breast cancer, immunotherapy in breast cancer, endocrine therapy in breast cancer

Contributions:

Role of the Immune system in triple-negative breast cancer – from prognosis to therapy

Endocrine therapy in metastatic breast cancer – more than just CDK4/6 inhibitors

Eric A. Singer

The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA

Research Interests: urologic oncology, kidney cancer, clinical trials, bioethics

Hailin Tang

Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, China

Research Interests: cancer, metastasis, proliferation, non-coding RNA

Special Issue:

Role of Non-Coding RNA in Cancer Drug Resistance

Molecular Mechanism and Targeted Therapy Strategy of Breast Cancer Metastasis and Drug Resistance

Giovanna Tosato

Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Research Interests: cancer, endothelial cells, vascular biology, hematopoietic stem cell niches

Contributions:

Bone marrow niches in myelodysplastic syndromes

Giovanni Tuccari

Department of Human Pathology "Gaetano Barresi", University of Messina, Messina, Italy

Research Interests: triple negative breast carcinomas, prognostic markers, HER2 heterogeneity, human pathology

Contributions:

Uterine large cell neuroendocrine carcinoma with unusual colonic metastasis

Changes in human epidermal growth factor receptor 2 status between primary breast/gastric carcinomas and synchronous metastatic lymph nodes: how can we explain them?

Special Issue:

Targeted Therapies and Predictive Biomarkers for Breast Cancer

Yogesh Vashist

Department of Surgery, Asklepios Harzklinik Goslar, Goslar, Germany

Research Interests: pancreatic cancer, microRNAs, long noncoding RNA

Special Issue:

Minimally Invasive Treatment of Esophageal Diverticulum

Cutting-Edge Innovations in Laparoscopic and Robotic Upper GI Surgery

Paula Videira

Departamento Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica, Portugal

Research Interests: cancer-associated glycans, dendritic cell-based vaccines, novel biomarkers in cancer

Valeria Visconte

Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA

Research Interests: myeloid malignancies, myelodysplastic syndromes, myeloid malignancies, acute myeloid leukemia (AML), paroxysmal nocturnal hemoglobinuria (PNH)

Israel Vlodavsky

Technion Integrated Cancer Center (TICC), Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

Research Interests: cancer metastasis, heparanase, extracellular matrix, tumor microenvironment in cancer progression

Xianwen Wang

School of Biomedical Engineering, Anhui Medical University, Hefei, China

Research Interests: cancer therapy, nanomedicine, biomaterials, drug delivery, nanotechnology

Special Issue:

Applications of Nanotechnology in Cancer Therapy: Advances and Challenges in Targeted Drug Delivery Systems

Innovative Nanomaterials in Wound Healing

Xiaojia Wang

Zhejiang Cancer Hospital, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, Hangzhou, Zhejiang, China.

Research Interests: early diagnosis of breast cancer

Yan Xue

Department of Oncology, Xi'an International Medical Center Hospital, Xi'an, Shaanxi , China.

Research Interests: breast cancer

Murali Yallapu

Department of Immunology and Microbiology, Institute for Cancer Immunotherapy, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, USA

Research Interests: nanotechnology, drug delivery, cancer, biomaterials, miRNA

Special Issue:

Pioneering Strategies to Combat Drug Resistance in Prostate Cancer

Qifeng Yang

Qilu Hospital, Shandong University, Jinan, Shandong, China

Research Interests: breast cancer, chemoresistance, metastasis, biomarker

Contributions:

The emerging roles of extracellular vesicles-mediated communications between breast tumor cells and cancer-associated fibroblasts

Special Issue:

The Emerging Role of Extracellular Vesicles in Cancer

Shun-Fa Yang

Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan

Research Interests: pharmacology, oral cancer metastasis, cancer biology, genetic polymorphism and environment risk factors in oral cancer

Special Issue:

Advances of Genomic Alterations in Oral Cancer

Haijun Yu

Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

Research Interests: targeted drug delivery system, immune regulation and vaccines

Vladimir Zaichick

Medical Radiological Research Center, Obninsk, Russia

Research Interests: in vivo and in vitro nuclear analytical methods of chemical element contents measurement in tissues and fluids of human body, age- and gender-dependence of chemical element contents in tissues and fluids, levels of chemical element contents in tissues and fluids as tumour’s markers

Contributions:

Significance of trace element quantities in the prostatic secretion of patients with benign prostatic hyperplasia and prostate cancer

Levels of chemical element contents in thyroid as potential biomarkers for cancer diagnosis (a preliminary study)

Hongyun Zhao

Collaborative Innovation Center for Cancer Medicine, Sun Yat- Sen University Cancer Center, Guangzhou, Guangdong, China

Research Interests: lung cancer, nasopharyngeal cancer, chemotherapy, targeted therapy, immunotherapy, clinical trials of anti-tumor new drugs

Special Issue:

New Therapies for Metastatic Non-Small Cell Lung Cancer

Bo Zhong

Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Wuhan University, Wuhan, Hubei, China.

Research Interests: myeloid cells, inflammation and autoimmunity, tumor microenvironment

Special Issue:

Inflammatory Mechanisms in Cancer Metastasis and Therapeutic Resistance

Founder and Editor-in-Chief Emeritus

Lucio Miele

Department of Genetics, School of Medicine, LSU Health Sciences Center, New Orleans, LA, USA

Research Interests: cancer stem cell-regulatory genes, GWAS, transcriptome, cancer-associated genes, genomic biomarkers, cancer health disparities

Contributions:

Introduction to Volume 1 Issue 2 of Journal of Cancer Metastasis and Treatment

Neuroendocrine tumors: current therapies, notch signaling, and cancer stem cells

All members of the Editorial Board have identified their affiliated institutions or organizations, along with the corresponding country or geographic region. OAE Publishing Inc. remains neutral with regard to any jurisdictional claims.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/